Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi").
- Bill Number
- H.Res. 848
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- International Affairs
- Status
- Introduced
- Latest Action
- 2025-10-31: Referred to the House Committee on Foreign Affairs.
- Last Updated
- 2026-05-12T08:06:01Z
AI-Generated Summary
Purpose
This House Resolution (H. Res. 848) expresses strong support for the United States' ongoing role in funding and partnering with Gavi, the Vaccine Alliance—a public-private organization that provides vaccines and immunization support to low-income countries. The goal is to save children's lives, prevent deadly diseases, and promote global health security by ensuring affordable access to vaccines.
Key Provisions
The resolution includes extensive background ("Whereas" clauses) highlighting Gavi's history, achievements, and future plans, followed by a "Resolved" section with six main affirmations:
- Affirms U.S. support for Gavi: Recognizes vaccine purchases through Gavi as a cost-effective way to reduce child and maternal deaths, aligning with U.S. goals for ending preventable deaths.
- Supports Gavi's core principles: Encourages introducing and scaling up new and routine immunizations, improving program sustainability, ensuring healthy vaccine markets, and strengthening health systems for equitable access.
- Recognizes health security benefits: Notes that U.S. support for Gavi helps protect American health by reducing global infectious disease risks.
- Encourages resource use: Urges the Department of State and Centers for Disease Control and Prevention (CDC) to leverage their maternal and child health and immunization resources to build local capacity in low-income countries for Gavi-supported vaccines.
- Calls for multiyear pledges: Emphasizes the need for predictable, long-term U.S. commitments to maximize Gavi's impact and attract other donors.
- Encourages increased investment: Pushes for greater U.S. funding during Gavi's 2026–2030 strategic period to expand vaccine access, including for malaria and other diseases.
Significant Changes to Existing Law
This is a non-binding resolution, not a law, so it introduces no changes to existing statutes or regulations. It serves as a formal statement of the House of Representatives' position to guide future policy and funding decisions without legal enforcement.
Potential Impacts
- On government agencies: Could influence the Department of State and CDC to prioritize Gavi-related programs in their budgets and operations, potentially increasing coordination with international partners and enhancing U.S. global health initiatives.
- On citizens: In low-income countries, it supports expanded vaccine access, potentially saving millions of lives from diseases like malaria, polio, and measles, while averting economic losses. For U.S. citizens, it bolsters domestic health security by curbing global outbreaks that could spread to America.
- On international relations: Strengthens U.S. leadership in global health diplomacy, fostering partnerships with organizations like the World Health Organization (WHO), UNICEF, and donor countries. It may encourage other nations to increase contributions, promoting stability in vaccine supply chains and reducing poverty through healthier populations.
Main Stakeholders Affected
- Low-income countries and their citizens: Primary beneficiaries, gaining access to vaccines for over 1 billion children since 2000, with focus on averting deaths from preventable diseases.
- U.S. government entities: Congress (for funding pledges), Department of State (maternal and child health programs), and CDC (immunization support).
- Gavi and partners: The Vaccine Alliance, including donors (e.g., Bill & Melinda Gates Foundation), vaccine manufacturers, WHO, UNICEF, and civil society groups, who rely on U.S. commitments for operations and market shaping.
- Global health community: Includes lower-income governments transitioning to self-funded programs and international initiatives like COVAX for pandemic response.
Notable Legal, Constitutional, or Political Implications
- Legal: As a simple resolution, it has no binding force and does not require Senate approval or presidential signature, limiting it to an expression of House intent rather than enforceable policy.
- Constitutional: Aligns with Congress's power to appropriate funds and conduct foreign affairs oversight (Article I, Section 8), but it avoids mandating spending, respecting separation of powers.
- Political: Signals bipartisan support (introduced by members from both parties) for global health aid, potentially influencing budget debates and U.S. foreign aid priorities. It highlights the high return on investment (e.g., $54 economic benefit per $1 spent) to build momentum for future appropriations, amid concerns over vaccine equity and U.S. global leadership.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (7)
Rep. Amo, Gabe [D-RI-1], Rep. Salazar, Maria Elvira [R-FL-27], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Lawler, Michael [R-NY-17], Rep. Auchincloss, Jake [D-MA-4], Rep. Mullin, Kevin [D-CA-15], Rep. Budzinski, Nikki [D-IL-13]
Recent Actions
- 2025-10-31: Referred to the House Committee on Foreign Affairs.
- 2025-10-31: Submitted in House
- 2025-10-31: Submitted in House
Bill Versions
- Supporting the role of the United States in helping save the lives of children and protecting the health of people in low-income countries with vaccines and immunization through Gavi, the Vaccine Alliance ("Gavi"). — issued 2025-10-31 — PDF (7 pages)